ITCI

Intra-Cellular Therapies Inc.

Delisted

ITCI was delisted on the 1st of April, 2025.

282 hedge funds and large institutions have $4.38B invested in Intra-Cellular Therapies Inc. in 2022 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 94 increasing their positions, 94 reducing their positions, and 36 closing their positions.

Holders
282
Holders Change
+9
Holders Change %
+3.3%
% of All Funds
4.55%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.1%
New
48
Increased
94
Reduced
94
Closed
36
Calls
$16.9M
Puts
$21M
Net Calls
-$4.11M
Net Calls Change
-$6.53M
Name Market Value Shares Shares
Change
Shares
Change %
SWM
301
SeaCrest Wealth Management
New York
-9,090 Closed
FRM
302
Fox Run Management
Connecticut
-8,357 Closed
LP
303
LMR Partners
United Kingdom
-7,900 Closed
BHCM
304
Boulder Hill Capital Management
New York
-7,500 Closed
CP
305
CenterBook Partners
Connecticut
-6,701 Closed
CC
306
Cipher Capital
New York
-5,308 Closed
ACM
307
AlphaCrest Capital Management
New York
-4,982 Closed
RJT
308
Raymond James Trust
Florida
-4,467 Closed
FAIM
309
Financial Advocates Investment Management
Washington
-2,788 Closed
QT
310
Quantbot Technologies
New York
-1,189 Closed
GWSG
311
GPS Wealth Strategies Group
Colorado
-1,000 Closed
IA
312
IFP Advisors
Florida
-401 Closed
DFCM
313
Dark Forest Capital Management
Puerto Rico
-114 Closed
EW
314
Evoke Wealth
California
-110 Closed
MA
315
MUFG Americas
New York
-7 Closed
CAL
316
Capital Advisors Ltd
Ohio
-6 Closed
GWS
317
Glassman Wealth Services
Virginia
-3 Closed
Nomura Asset Management
318
Nomura Asset Management
Japan
CI Investments Inc
319
CI Investments Inc
Ontario, Canada
$0 5
CFGS
320
Concourse Financial Group Securities
Alabama
Wolverine Trading
321
Wolverine Trading
Illinois